Quantum Pharma PLC (LSE:QP.) - Share price - Overview

Stock Report

Quantum Pharma PLC QP.

Last Price
GBX60.50

Day Change
3.75|6.61%

As of 22/05/2017
16:52:22 BST | GBX
Minimum 15 Minutes Delay.

Last Close56.75p
Day Range56.12 - 62.00
Mkt Cap95.97Mil
52-Wk Range32.75 - 91.70
Yield %1.65
ISINGB00BRTL8Q42
Volume352,858
P/E-10.40
P/S1.08
P/CF10.84

Share Price

Total Returns 19/05/2017

 Chg (%)  
More ...
Quantum Pharma PLC39.26 
FTSE 100 TR GBP5.63
 
Financials
201520162017
More ...
Income Statement
Turnover61.7269.99-
Operating Profit6.676.96-
Net Profit0.725.60-
Reported EPS0.564.30-
Balance Sheet
Current Assets21.3322.84-
Non Current Assets61.2184.50-
Total Assets82.54107.35-
Current Liabilities16.3928.18-
Total Liabilities31.8251.84-
Total Equity50.7255.51-
Cash Flow
Operating Cash Flow2.927.61-
Net Change in Cash1.59-1.63-
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
20188.123.74-15.18---
20199.454.2814.3913.270.92--
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
11/11/2016PurchaseMr. Ian Johnson34.0058,82420,000.00
11/11/2016PurchaseDr. John Brown34.0073,52925,000.00
11/11/2016PurchaseChris Rigg34.00147,05950,000.00

Company Profile

Quantum Pharma PLC is engaged in the manufacture, procurement and supply to UK pharmacy chains, wholesalers and hospitals of Specials and Special Obtains. Specials are medicines which are not licensed for general manufacture.

Sector

Drug Manufacturers - Specialty & Generic

Market Position

922 of 1851 Companies

Index

FTSE AIM All Share

Outlook

(03/05/2017) ch - "The board is confident in the future prospects of the group and we look forward to reporting on further strategic progress as we move forward"

Next Event 13/06/2017

Next annual report due
Ratios
CompSecMkt
More ...
PER (E)14.5614.9216.62
Div Yld (E)0.003.594.09
PEG (E)0.000.400.58
ROCE0.00184.1016.56
Op Mrgn0.00-7.440.13
EPS Grwth0.0059.4129.13
Dividends
PreviousLatest
More ...
Record Date30/10/1521/10/16
Ex-Div29/10/1520/10/16
Paid20/11/1507/11/16
Amnt0.501.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Ian Johnson
Chief Executive OfficerChris Rigg
Chief Financial OfficerGed Murray
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.